Leigh B. Bangs, Ph.D.

Dr. Bangs founded Bangs Laboratories, a leading supplier of microspheres for the biomedical/diagnostic fields. In the 33 years following his graduate education in surface chemistry at MIT, he has held several management and technical positions in the chemical and diagnostics industries. He has actively worked with Latex Particles for over 25 years and his technical manual, UNIFORM LATEX PARTICLES, is distributed worldwide.

J. Michael Brinkley, Ph.D.

Dr. Brinkley is a physical organic chemist with over 20 years of industrial experience in bio-organic chemistry and medical diagnostics research and development. He has held management positions at Syva Company and Molecular Probes, Inc., and is currently Vice President of Research at Emerald Diagnostics, Inc., directing research in the area of latex-based diagnostics. He has developed a wide range of unique fluorescent latex particles and has authored several recent patents and publications on fluorescent latex and chemical modification of proteins.

Donald E. Brooks, Ph.D.

Dr. Brooks is Professor of Pathology and Chemistry at the University of British Columbia, Vancouver, B.C. He has over 25 years of academic and professional surface chemistry and biochemistry experience. Dr. Brooks has over 100 publications, has edited 2 textbooks and holds 3 patents.

Mohamed S. El-Aasser, Ph.D.

Dr. El-Aasser is the Iacocca Professor of Engineering and Applied Sciences and the Director of the Emulsion Polymers Institute at Lehigh University, Bethlehem, PA, U.S.A. He has over 25 years of research work in emulsion polymerization and polymer colloids, which are documented in more than 200 technical publications, three edited books, and 8 U.S. patents. He is a major consultant to industry in all aspects of emulsion polymerization and latex technology, which includes emulsion polymerization and emulsification processes, surface and colloidal properties of latexes and their film formation.

Paul R. Hemmes, Ph.D.

Dr. Hemmes has held senior academic positions at Rutgers University and has also worked in both research and manufacturing companies in the diagnostics industry. He has published 60 papers and 8 patents. He has been involved for the past 12 years with the problems associated with technology transfer between research and manufacturing. Dr. Hemmes is Vice President of Operations for Abaxis, Inc. Sunnyvale, California.

Jack Kettman, Ph. D.

Dr. Kettman is Professor of Microbiology at the University of Texas Southwestern Medical Center at Dallas, Texas and Director of the Dallas Cell Analysis Facility. For the past 20 years, he has studied clonal development and lymphocyte activation, especially analysis of gene expression during T-cell activation. More recently Dr. Kettman has pursued innovative uses of microsphere and flow cytometric technology to develop multiplex analytical approaches to diagnostic assays. He has authored over 200 publications.

Robert J. Knox, Ph.D.

Dr. Knox is a biochemist with substantial research experience in the electrophoretic characterization of biological particle surfaces. He has applied analytical particle electrophoretic methods to latex processing problems in both the R & D and manufacturing settings, ranging from characterization of latex starting materials and monitoring steps in latex coating to troubleshooting various latex processing problems. Dr. Knox is Vice President of Emerald Diagnostics, Inc. in Eugene, Oregon.

Orjan Olsvik, Ph. D.

Dr. Olsvik is professor and chairman of the Department of Medical Microbiology at University of Tromso School of Medicine and University Hospital in Tromso, Norway. As a medical microbiologist with experience in molecular diagnosis and epidemiology, he has developed applications of immunomagnetic separation to cells and molecules used in diagnosis of infectious diseases. Dr. Olsvik was elected a member of the American Academy of Microbiology in 1992. He is the author of 100 publications and 6 books.

James L. Sackrison

Mr. Sackrison is an immunochemist with over 10 years experience in diagnostic assay development. He is well known for innovative conjugation and assay design and has developed numerous commercial immunoassays which have become leading technologies. As the president of Lakeland Biomedical, Inc., Mr. Sackrison consults with a number of prominent diagnostic companies in the development of esoteric immunoassays.

Geoffrey V.F. Seaman, Ph.D.

Dr. Seaman has held senior academic and industrial positions in production, development and marketing of latexes, latex products, and biomedical devices. He has more than 30 years experience in the surface chemical, biochemical and biophysical sciences. He is the author of more than 200 publications and 3 books. Dr. Seaman is currently President of Emerald Diagnostics, Inc.